Eligibility Criteria for the Use of Delamanid [Dlm] in MDR/RR-TB Treatment
Eligibility Criteria for the Use of Delamanid [Dlm] in MDR/RR-TB Treatment
Eligibility Criteria for the Use of Delamanid [Dlm] in MDR/RR-TB Treatment
Rationale for Grouping of Anti-TB Drugs
Drugs Not Included in Groups A - C and Rationale for Non-inclusion
Constituents of Patient-wise Boxes [PWB] for Isoniazid [H] Mono/Poly DR-TB Regimen
Guidelines for Issuing Bedaquiline and Delamanid to the Patient
Role of the State Drug Store [SDS] in the Constitution of Patient-wise Boxes
Management of DR-TB ADR: Diarrhoea and/or Flatulence
Management of DR-TB Patients: Lost to Follow-u